We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.35 | 4.20 | 4.50 | 4.35 | 4.35 | 4.35 | 107,473 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.36 | 23.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
07/5/2020 14:52 | Investing,I'm in agreement with you that the announced deals look full of potential to those who keep a close eye and even better for those like myself who dig around and make wild assumptions.However like Chrischas keeps reminding us, rightly so imo, this is not adding to the in the coming months revenue picture which amplifies the CAP/TT/ Molluscicide habitual habitual consistent inconsistency habitual habitual consistent inconsistency habitual habitual consistent inconsistency habitual habitual consistent inconsistency reputation which means folks with less conviction and back ground research than you and I will keep their powder dry just like Kenmitch. | quazie12 | |
07/5/2020 14:49 | Mr macgregorThe share to which you refer had a placing at 80p when it was trading at £3. The placing represented roughly 20% of shares in issue so buy at £2 (without benefit of hindsight) was maybe not as stupid if you do the maths and bear in mind that company likely has commercially viable product pipeline | quazie12 | |
07/5/2020 14:04 | But your not able to reference a single post to make your Evangelist case.:) | supersonico | |
07/5/2020 14:01 | Good grief Super !!You have posted really massive amounts of information on here on a daily basis for umpteen years. At first I took it as rampant ramping then realised it wasnt. Hi Sorry but in my book you are/were an Eden fanatic. "Zealously advocating a particular cause" that's an Wvangelist | quazie12 | |
07/5/2020 13:55 | I wonder if this Fraudy fella can say Corteva? | supersonico | |
07/5/2020 13:26 | Hey Q12, Perhaps you could give me an example or two of what you describe as my Evangelistic posts. | supersonico | |
07/5/2020 13:12 | No I'm shocked you have not moved on SS. I do note that your evangelistic posting of everything Eden has waned into a more acerbic approach. Seriously the best thing might be finally admit your investment is unlikely to yield much. I did thAt and took the loss on the chin. Retail shareholders are not on the Board's list of priorities.Q12 | quazie12 | |
07/5/2020 11:27 | Hey Q12, I'll bet a lot of investors will be shocked by your news. | supersonico | |
07/5/2020 11:20 | I no longer own any shares in this total dog company thankfully. Eden have successfully raised and squandered more equity (£43m) over the last 15 years than they have ever achieved in gross sales attributable to the IP and thats counting "gross" sales not the royalties earned. Current crisis aside they still don't have a business model attractive enough for investors hence 6p SP | quazie12 | |
07/5/2020 10:34 | The man who can't say Cedroz has never been so ineffectual or impotent as he has been here. 'working' not the word I'd use . He's the year on year embarrassing underperformer in the LUBE brand roster. And that takes some doing. | supersonico | |
07/5/2020 10:21 | Indeed, at least the IP continues to progress but the investor communications is pathetic. | supersonico | |
07/5/2020 10:07 | Indeed the dampener of C19 has left its mark on Eden as well as so many businesses. However, before throwing oneself off a bridge, do bear in mind KPMG, the auditors, signed off on the impairment review of the intangible asset (the cost of the IP). I Extract from Note 12 "...Management's forecasts include growth rates ranging from 101% in year one to 21% in year six, with an average annual growth rate of 64%. This is considered to be reasonable based on information from and discussion with strategic partners and the stage in growth that the Company is at, with a number of new products being introduced over the coming years, as well as significant new geographical markets being entered into or the first time." Bear in mind these projections are not maximum, they are simply to demonstrate the IP is in no way worth less than the value in the accounts. So a growth rate of 101% gives is some £3.4m for product sales. This compares to £3.6m in Cenkos' projections. While we are in the middle of uncertainty of how life will be post launch of C19, we do know life will improve. Many governments around the world are easing restrictions and while life may not return to as it was before, the regulators too will have to return to work. Eden's IP works. Eden's products work and in many respects are an improvement on the multi million products they replace. So, we will gain the approvals. (It is worth noting that at this moment the EU MS are some 8 months late in providing approvals based upon their own rules.) While maddeningly frustrating, there are few companies with the potential attributed to Eden. While today is not Eden's day, it is getting to be extremely close. Sustaine works. The seed treatment opportunity is real and enormous. I have every confidence we will be producing sustaine encapsulated seeds, if not next year, then the year after. This will contribute many millions of profit very quickly. Off for a walk in the beautiful sunshine. | attyg | |
07/5/2020 08:55 | 'I agree erinvale, a dose of realism needs to be injected into the commentary from Eden's directors'. Says the unrealistic lube fella that can't say Cedroz...LOL | supersonico | |
07/5/2020 08:49 | We invest for returns and what have SS/AA et al actually delivered except the same old same old, they treat us like mushrooms and expect us to think that they have our backs.. absolute rubbish... they are riding the gravy train... I cannot believe I've wasted so much time on this..Root and branch change with Comms and attitude Eden .. disgraceful.. | bjlk | |
07/5/2020 08:06 | Results: it is difficult to comprehend the mindset of a company that issues this ‘jam tomorrow’ annual statement, in the face of lower revenues, increased operating loss and negligible increase in sales. Eden’s annual statement has spouted optimism for the past 20+ years and consistently failed to deliver. In doing so it treats shareholders with contempt. Eden’s hapless management needs to shape up and provide a realistic assessment of prospects, instead of yet another dose of less than credible, over-optimistic guff. | erinvale | |
07/5/2020 07:52 | Not the old 'back to school market..'. that looks less credible than ever. | brucie5 | |
06/5/2020 20:46 | PSU TreeFruit Doctor @drtreefruit · 8h Disease picture time: that’s not snow...it’s a raging case of powdery mildew already in my Rome research block. | supersonico | |
06/5/2020 17:42 | Results out tomorrow Notice of Results Eden Research plc (AIM: EDEN), the AIM-quoted company focused on sustainable biopesticides for use in global crop protection, animal health and consumer products industries, announces that its preliminary results for the period ending 30 December 2019 will be issued on Thursday 7 May 2020. | monet | |
06/5/2020 15:26 | Pondinan , It's the Dampness that Eden Shareholders enjoy reading about. | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions